According to different sources, deactivating a virus for a vaccine means rendering it non-infectious without destroying the structures (antigens) that the immune system recognizes. In concrete terms, here are the primary methods used:
Chemical Inactivation: Traditionally, viruses are deactivated by growing them in controlled cell cultures and then exposing them to specific chemicals. A common agent is formaldehyde, though beta-propiolactone (BPL) is also frequently used. These chemicals work by cross-linking the proteins and nucleic acids of the virus, which prevents it from replicating. The procedure involves carefully controlling the chemical concentration, temperature, duration of exposure, and even the mixing or stirring of the solution. These parameters must be calibrated precisely: too little inactivation can leave residual infectious particles, while too much may denature the viral proteins and damage the antigenic sites necessary to trigger a robust immune response. In practice, once the virus is sufficiently "killed" by the chemical, it no longer causes disease but still presents the immune system with a familiar structure for recognition.
Physical Inactivation (Irradiation): An alternative method that has been gaining attention is using irradiation, specifically electron beam irradiation. In this process, the virus is exposed to a controlled dose of ionizing radiation. The energy from the electrons damages the genetic material (the viral nucleic acids) while generally leaving the outer protein structures intact. This method eliminates the need for toxic chemicals, speeds up the inactivation process, and can result in a pure and highly specific vaccine in its antigen presentation. The technology is especially attractive from an environmental standpoint, as it avoids producing chemical waste and often requires shorter processing times.
In both cases, the main goal is to maintain enough of the virus's structure so that when the inactivated virus is introduced into the body, the immune system can "learn" to recognize it without risk of infection. The chosen method depends on factors like the virus's characteristics, production scalability, regulatory standards, and the desired immune response. The field continually evolves, with research focusing on optimizing these methods to maximize safety and efficacy while minimizing side effects and production complexity. For instance, innovations using irradiation are being developed to produce vaccines requiring lower doses or better immunogenic profiles by preserving critical antigenic sites with even greater fidelity.
Viruses are deactivated for vaccines using several well-established methods, depending on the type of virus and the desired vaccine formulation. The primary approaches include:
Chemical Inactivation: Agents like formaldehyde, beta-propiolactone, and detergents disrupt viral proteins or nucleic acids, rendering the virus non-infectious while preserving its antigenic properties.
Physical Methods: Heat treatment, UV radiation, and gamma irradiation can denature viral components, preventing replication while maintaining immunogenicity.
Biochemical Approaches: Some vaccines use enzyme-based degradation or photoactive compounds (e.g., psoralens) to selectively inactivate viral particles.
Genetic Modification: Live attenuated vaccines involve genetic alterations that weaken the virus, allowing it to stimulate immunity without causing disease.
Each method is carefully optimized to ensure vaccine safety and efficacy. You can explore more details here and here.